Collaboration - August 31, 2022
Kaiku Health expands partnership with Novartis
Last year Kaiku Health announced its collaboration with Novartis in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership, they state. “The cooperation so far has shown that together we can enhance the monitoring and symptom management of […]
Collaboration - August 30, 2022
Zerion Pharma collaborates with Insud Pharma
Zerion Pharma and the Spanish pharmaceutical group Insud Pharma will develop and commercialize drug products applying ZERION’s Dispersome technology. Zerion will develop Dispersome formulations of marketed drug products while Insud will be responsible for the finished product dosage form, the clinical development as well as global marketing and sales of the final products. A worldwide […]
Collaboration - August 17, 2022
Genmab and BioNTech expand global strategic collaboration
The two companies have announced an expansion of their collaboration to develop and commercialize novel immunotherapies for the treatment of cancer patients. Under the expansion, Genmab and BioNTech will jointly work to research, develop, and commercialize novel monospecific antibody candidates for various cancer indications. Since 2015, the companies have been working on the joint development […]
Collaboration - July 13, 2022
Orion and MSD announce global collaboration
Orion Corporation and MSD have announced a global development and commercialisation agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1 (CYP11A1), an enzyme important in steroid production. ODM-208 is an oral, non-steroidal inhibitor of CYP11A1 currently being evaluated in a Phase 2 clinical trial for the treatment of patients with metastatic […]
Collaboration - June 28, 2022
Reinforced Swedish-Norwegian cancer cooperation
A Memorandum of Understanding (MoU) was signed between the University of Oslo and the Karolinska Institute during a visit by the Norwegian Crown Prince Couple and a Norwegian industry delegation in Stockholm on 2 May. “Norway and Sweden must work together towards making precision medicine a standard for all cancer patients,” says Ketil Widerberg, general […]
Collaboration - June 25, 2022
Cross-Atlantic collaboration to raise visibility for Swedish AMR innovations
The life science industry organization SwedenBIO pushed for stronger global collaborations on antimicrobial resistance (AMR) at the BIO International Convention in San Diego, U.S., earlier in June. The organization also strengthened the Swedish participation in the International Council of Biotech Associations (ICBA) by taking over the chair on AMR issues. The AMR threat may not […]
